Loguercio, C., D'Argenio, G., Delle Cave, M., Cosenza, V., Della Valle, N., Mazzacca, G., & Del Vecchio Blanco, C
The area postrema, which lacks a blood-brain barrier, detects circulating signals and can trigger nausea
Dosing, Administration, and Best Practices Recommended Dosing Protocols Dosing for BPC-157 TB-500 nasal spray varies based on individual goals, body weight, and the specific concentration of the formulation: Typical BPC-157 Dosing Maintenance: 250-500 mcg per day Active recovery: 500-750 mcg per day Acute injury: 750-1000 mcg per day (divided doses) Typical TB-500 Dosing Maintenance: 2-2.5 mg twice weekly Loading phase: 5-10 mg weekly (first 4-6 weeks) Maintenance phase: 2-5 mg weekly thereafter Combined Nasal Spray Formulations often provide both peptides in ratios designed for convenient once or twice-daily administration
Therefore, developing optical probes to track ChaC1/ChaC2 in vivo or in vitro is key for fully realizing the clinical potential of ChaC1/ChaC2 as tumor markers
In addition to their cosmetic benefits, fat dissolving injections have been shown to provide health benefits as well